These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 28981623

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Núñez-Gómez L, Mesonero-Gismero F, Albillos-Martínez A, López-Sanromán A.
    Gastroenterol Hepatol; 2018 Nov; 41(9):576-582. PubMed ID: 30054143
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
    Cholapranee A, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN.
    Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Inflammatory bowel disease].
    Patuto N, Beglinger C.
    Praxis (Bern 1994); 2013 Aug 21; 102(17):1046-52. PubMed ID: 23965717
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy.
    Hlavaty T, Krajcovicova A, Letkovsky J, Sturdik I, Koller T, Toth J, Huorka M.
    Bratisl Lek Listy; 2016 Aug 21; 117(4):205-11. PubMed ID: 27075383
    [Abstract] [Full Text] [Related]

  • 32. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?
    Subramanian S, Ekbom A, Rhodes JM.
    Gut; 2017 Feb 21; 66(2):362-381. PubMed ID: 27802156
    [Abstract] [Full Text] [Related]

  • 33. Review article: maintenance treatment of Crohn's disease.
    Biancone L, Tosti C, Fina D, Fantini M, De Nigris F, Geremia A, Pallone F.
    Aliment Pharmacol Ther; 2003 Jun 21; 17 Suppl 2():31-7. PubMed ID: 12786610
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.
    Gisbert JP, Gomollón F, Hinojosa J, López San Román A.
    J Crohns Colitis; 2010 Nov 21; 4(5):567-74. PubMed ID: 21122561
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Jung YS, Han M, Park S, Cheon JH.
    Dig Dis Sci; 2020 May 21; 65(5):1436-1444. PubMed ID: 31677070
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Thromboembolism as an important complication of inflammatory bowel disease.
    Bollen L, Vande Casteele N, Ballet V, van Assche G, Ferrante M, Vermeire S, Gils A.
    Eur J Gastroenterol Hepatol; 2016 Jan 21; 28(1):1-7. PubMed ID: 26513610
    [Abstract] [Full Text] [Related]

  • 40. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
    Kluthe C, Tsui J, Spady D, Carroll M, Wine E, Huynh HQ.
    Can J Gastroenterol Hepatol; 2018 Jan 21; 2018():4687041. PubMed ID: 29682493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.